To find the most relevant journal, please insert appropriate keyword to facilitate search.
Search Results: CPSP
Current Psychopharmacology
ISSN: 2211-5560 (Print)
eISSN: 2211-5579 (Online)
Editor-in-Chief:
Western University Health Sciences
Pomona, CA
USA
Special Issues With Active Call for Papers
PD-1 Inhibitors in Neuroprotection: Modulating Neurotransmitter Pathways for Therapy
Programmed cell death protein-1 (PD-1) inhibitors, widely recognized for their role in immunotherapy, have recently emerged as potential neuroprotective agents. Beyond their traditional application in oncology, PD-1 inhibitors influence neuroimmune interactions, impacting neurotransmitter pathways critical for maintaining brain homeostasis. Dysregulation of these pathways is implicated in neurodegenerative and neuropsychiatric disorders, including Parkinson’s disease, Alzheimer’s disease, and depression. By modulating immune responses, PD-1 blockade may reduce neuroinflammation, enhance neuronal survival, and restore neurotransmitter balance. Recent studies... see more
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the current pharmacotherapeutic approaches to treating mental illnesses as well as drug delivery approaches that have improved existing therapies. Approaches to improve drug bioavailability, provide controlled... see more